BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 18573428)

  • 1. Persistent N2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy.
    Mansour Z; Kochetkova EA; Santelmo N; Ducrocq X; Quoix E; Wihlm JM; Massard G
    Ann Thorac Surg; 2008 Jul; 86(1):228-33. PubMed ID: 18573428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
    Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
    Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits.
    Doddoli C; Barlesi F; Trousse D; Robitail S; Yena S; Astoul P; Giudicelli R; Fuentes P; Thomas P
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):416-25. PubMed ID: 16077407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
    J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients.
    Stefani A; Alifano M; Bobbio A; Grigoroiu M; Jouni R; Magdeleinat P; Regnard JF
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):356-63. PubMed ID: 20381815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
    Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumonectomy after chemotherapy: morbidity, mortality, and long-term outcome.
    Alifano M; Boudaya MS; Salvi M; Collet JY; Dinu C; Camilleri-Broët S; Régnard JF
    Ann Thorac Surg; 2008 Jun; 85(6):1866-72; discussion 1872-3. PubMed ID: 18498785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of superior sulcus tumors: results and prognostic factors.
    Demir A; Sayar A; Kocaturk CI; Gunluoglu MZ; Akýn H; Metin M; Cansever L; Olcmen A; Dincer SI; Bedirhan MA; Gurses A
    Thorac Cardiovasc Surg; 2009 Mar; 57(2):96-101. PubMed ID: 19241311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
    Kim AW; Faber LP; Warren WH; Basu S; Wightman SC; Weber JA; Bonomi P; Liptay MJ
    Ann Thorac Surg; 2009 Sep; 88(3):937-43; discussion 944. PubMed ID: 19699924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results.
    Lococo F; Cesario A; Margaritora S; Dall'Armi V; Nachira D; Cusumano G; Meacci E; Granone P
    Ann Thorac Surg; 2012 May; 93(5):1633-40. PubMed ID: 22480394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
    Van Meerbeeck JP; De Pauw R; Tournoy K
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.
    Van Schil PE
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):718; author reply 718-9. PubMed ID: 18329516
    [No Abstract]   [Full Text] [Related]  

  • 16. 15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer.
    Shargall Y; de Perrot M; Keshavjee S; Darling G; Ginsberg R; Johnston M; Pierre A; Waddell TK
    Lung Cancer; 2004 Sep; 45(3):357-63. PubMed ID: 15301876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer.
    Petersen RP; Pham D; Burfeind WR; Hanish SI; Toloza EM; Harpole DH; D'Amico TA
    Ann Thorac Surg; 2007 Apr; 83(4):1245-9; discussion 1250. PubMed ID: 17383320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional pulmonary resections after pneumonectomy: actual long-term survival and functional results.
    Grodzki T; Alchimowicz J; Kozak A; Kubisa B; Pieróg J; Wójcik J; Bielewicz M; Witkowska D
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):493-8. PubMed ID: 18583143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
    Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.
    Jaklitsch MT; Herndon JE; DeCamp MM; Richards WG; Kumar P; Krasna MJ; Green MR; Sugarbaker DJ
    J Surg Oncol; 2006 Dec; 94(7):599-606. PubMed ID: 17039491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.